Cargando…

Chronic kidney disease is associated with adverse outcomes among elderly patients taking clopidogrel after hospitalization for acute coronary syndrome

BACKGROUND: Chronic kidney disease (CKD) is associated with worse outcomes among patients with acute coronary syndrome (ACS). Less is known about the impact of CKD on longitudinal outcomes among clopidogrel treated patients following ACS. METHODS: Using a retrospective cohort design, we identified p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fischer, Michael J, Ho, P Michael, McDermott, Kelly, Lowy, Elliott, Parikh, Chirag R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668174/ https://www.ncbi.nlm.nih.gov/pubmed/23688069 http://dx.doi.org/10.1186/1471-2369-14-107

Ejemplares similares

Colonoscopy with Polypectomy in Patients Taking Clopidogrel
por: Friedland, Shai, et al.
Publicado: (2009)

Photoselective vaporization of the prostate in men taking clopidogrel
por: Spernat, Daniel M. G., et al.
Publicado: (2011)

Factors associated with presenting >12 hours after symptom onset of acute myocardial infarction among Veteran men
por: McDermott, Kelly, et al.
Publicado: (2012)

Traumatic Retropharyngeal Hematoma in a Patient Taking Clopidogrel
por: Betten, David P., et al.
Publicado: (2018)

The elderly acute coronary syndrome patient: a neglected population?
por: Turley, A, et al.
Publicado: (2007)

Cerebral microbleeds in patients with ischemic cerebrovascular disease taking aspirin or clopidogrel
por: Ge, Lihong, et al.
Publicado: (2019)

Risk of postpolypectomy bleeding in patients taking direct oral anticoagulants or clopidogrel
por: Kim, Gwang-Un, et al.
Publicado: (2021)

Hemorrhagic herpes zoster duplex unilateralis in a patient taking clopidogrel
por: Miller, Austinn C., et al.
Publicado: (2023)

Efficacy and safety outcomes of ticagrelor compared with clopidogrel in elderly Chinese patients with acute coronary syndrome
por: Wang, Huidong, et al.
Publicado: (2016)

Thrombocytopenia Induced by Clopidogrel: A Rare Adverse Effect
por: Távora, Catarina, et al.
Publicado: (2023)

New genetic variants associated with major adverse cardiovascular events in patients with acute coronary syndromes and treated with clopidogrel and aspirin
por: Liu, Xiaomin, et al.
Publicado: (2021)

An Examination of Clopidogrel in the Treatment of Coronary Microvascular Disease
por: Iskandar, Nicholas P, et al.
Publicado: (2022)

CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt
por: Shawky, Ahmed, et al.
Publicado: (2023)

Adjunctive Cilostazol versus High Maintenance Dose of Clopidogrel in Patients with Hyporesponsiveness to Chronic Clopidogrel Therapy
por: Lee, Ga Yeon, et al.
Publicado: (2013)

Clopidogrel-taking behavior by drug-eluting stent patients: Discontinuers versus continuers
por: Decker, Carole, et al.
Publicado: (2008)

Effects of Clopidogrel on Mortality, Cardiovascular and Bleeding Outcomes in Patients with Chronic Kidney Disease - Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry
por: Lin, Tsung-Hsien, et al.
Publicado: (2013)

Risk factors for adverse drug reactions associated with clopidogrel therapy
por: Mugosa, Snezana, et al.
Publicado: (2022)

Ticagrelor vs. Clopidogrel in Acute Coronary Syndrome Patients With Chronic Kidney Disease After New-Generation Drug-Eluting Stent Implantation
por: Roh, Ji Woong, et al.
Publicado: (2022)

Long-term risk of chronic kidney disease and mortality in children after acute kidney injury: a systematic review
por: Greenberg, Jason H, et al.
Publicado: (2014)

Determinants to optimize response to clopidogrel in acute coronary syndrome
por: Giusti, Betti, et al.
Publicado: (2010)

Acute kidney injury: taking aim at colistin
por: Rashid, Shayan, et al.
Publicado: (2014)

Acute myocardial infarction occurring while on chronic clopidogrel therapy (‘clopidogrel failure’) is associated with high incidence of clopidogrel poor responsiveness and stent thrombosis
por: Regev, Ehud, et al.
Publicado: (2018)

The impact of cytochrome 450 and Paraoxonase polymorphisms on clopidogrel resistance and major adverse cardiac events in coronary heart disease patients after percutaneous coronary intervention
por: Zhang, Zhaowei, et al.
Publicado: (2020)

Time Course of Ischemic and Bleeding Burden in Elderly Patients With Acute Coronary Syndromes Randomized to Low‐Dose Prasugrel or Clopidogrel
por: Crimi, Gabriele, et al.
Publicado: (2019)

Efficacy and safety of potent P2Y12 inhibitors vs. clopidogrel in elderly patients with acute coronary syndrome
por: Luo, Li-Man, et al.
Publicado: (2020)

Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in Elderly Patients Undergoing Percutaneous Coronary Intervention: A Cohort Study
por: Meng, Shaoke, et al.
Publicado: (2022)

The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel
por: Choi, Woong Gil, et al.
Publicado: (2021)

Hypoglycemia as a potential risk for patients taking clopidogrel: A systematic review and meta-analysis
por: Chen, Shi, et al.
Publicado: (2023)

Effect of Ticagrelor Versus Clopidogrel on Aortic Stiffness in Patients With Coronary Artery Disease
por: Vlachopoulos, Charalambos, et al.
Publicado: (2019)

Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
por: Sharma, Rakesh K, et al.
Publicado: (2009)

Pharmacoeconomic Analysis of Clopidogrel in Secondary Prevention of Coronary Artery Disease
por: Cheng, Judy W.
Publicado: (2007)

The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention
por: Giantini, Astuti, et al.
Publicado: (2023)

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Norgard, Nicholas B, et al.
Publicado: (2009)

Comparison of Safety and Efficacy Between Clopidogrel and Ticagrelor in Elderly Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
por: Zhao, Xiangkai, et al.
Publicado: (2021)

Acute-onset severe gastrointestinal tract hemorrhage in a postoperative patient taking rivaroxaban after total hip arthroplasty: a case report
por: Boland, Michael, et al.
Publicado: (2012)

Impact of Clopidogrel Stop Interval on Major Adverse Bleeding Events in Cardiac Surgery
por: Huo, Bright, et al.
Publicado: (2021)

The Risk of Bleeding and Adverse Events with Clopidogrel in Elective Hip and Knee Arthroplasty Patients
por: Wu, Cheng-Ta, et al.
Publicado: (2022)

Long COVID and kidney disease
por: Yende, Sachin, et al.
Publicado: (2021)

The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
por: Kulik, Alexander, et al.
Publicado: (2005)

Comparison of prasugrel and clopidogrel reloading on high platelet reactivity in clopidogrel-loaded patients undergoing percutaneous coronary intervention (PRAISE-HPR): a study protocol for a prospective randomized controlled clinical trial
por: Lee, Dong-Hyun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_348mfk0o84u8jmvq6kkj946kaj